TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Working Group to Look At Guidelines, Mandates, Centers Role In Prevention, Cancer Control February 17, 1984
TCL Archive NCAB Agrees With NCI Recommendation To Drop PO1 Chartered Committees, Adopt Single Review February 13, 1987
TCL Archive AACR, NCCR Advocate Five-Year Plan to Reach $10 billion Annual Cancer Budget April 30, 1999
